Rubedo Life Sciences Company
Biotechnology company founded in 2018 in Mountain View, California. Rubedo develops small-molecule therapies targeting age-associated cell populations, such as senescent and pro-inflammatory cells, with tissue selectivity. Its “ALEMBIC™” drug discovery platform combines single-cell profiling and chemistry to create precision geroscience therapeutics. (rubedolife.com)
Investors
Headquarters:
428 Oakmead Parkway, Sunnyvale, CA 94085, United States.
Founded Date:
2018
Estimated Revenue:
No public info